liarozole has been researched along with Ichthyosis, Lamellar in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, D; Blockhuys, S; Didona, B; Steijlen, P; Traupe, H; Vahlquist, A; van Rossem, K | 1 |
| Blockhuys, S; Borgers, M; Gånemo, A; Pavez Loriè, E; Törmä, H; Vahlquist, A; van de Plassche, L; Wouters, L | 1 |
2 trial(s) available for liarozole and Ichthyosis, Lamellar
| Article | Year |
|---|---|
Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Dermatologic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ichthyosis, Lamellar; Imidazoles; Male; Middle Aged; Treatment Outcome; Young Adult | 2014 |
Expression of retinoid-regulated genes in lamellar ichthyosis vs. healthy control epidermis: changes after oral treatment with liarozole.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biomarkers; Dermatologic Agents; Double-Blind Method; Female; Humans; Ichthyosis, Lamellar; Imidazoles; Interleukin-1alpha; Male; Middle Aged; Polymerase Chain Reaction; Receptors, Retinoic Acid; RNA, Messenger; Skin; Tretinoin; Tumor Necrosis Factor-alpha | 2009 |